XML 54 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Of Financial Instruments
 6 Months Ended
Dec. 31, 2011
Fair Value Of Financial Instruments [Abstract]  
Fair Value Of Financial Instruments

(9) Fair Value of Financial Instruments

Accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, the Company is required to classify certain assets and liabilities based on the fair value hierarchy, which groups fair value measured assets and liabilities based upon the following levels of inputs:

 

  •  

Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; and

 

  •  

Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

 

  •  

Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

The assets and liabilities maintained by the Company that are required to be measured at fair value on a recurring basis include the Company's various debt instruments, deferred compensation plan investments, outstanding foreign exchange forward contracts and contingent consideration owed to the previous owners of CDC. The carrying value of debt listed in Note 7 is considered to approximate fair value, as the Company's debt instruments are indexed to LIBOR or the prime rate using the market approach (Level 2 criteria). The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis as of December 31, 2011:

     Total      Quoted
prices in
active
markets
(Level 1)		      Significant
other
observable
inputs
(Level 2)		      Significant
unobservable
inputs
(Level 3)		  
     (in thousands)  

Assets:

            

Deferred compensation plan investments, current and non-current portion

    $ 11,705       $ 11,705       $ —         $ —     

Forward foreign currency exchange contracts

      343         —           343         —     
  

 

 

     

 

 

     

 

 

     

 

 

  

Total assets at fair value

    $ 12,048       $ 11,705       $ 343       $ —     
  

 

 

     

 

 

     

 

 

     

 

 

  

Liabilities:

            

Forward foreign currency exchange contracts

    $ 12       $ —         $ 12       $ —     

Liability for contingent consideration, current and non-current portion

      20,002         —           —           20,002   
  

 

 

     

 

 

     

 

 

     

 

 

  

Total

    $ 20,014       $ —         $ 12       $ 20,002   
  

 

 

     

 

 

     

 

 

     

 

 

  

 

The investments in the deferred compensation plan are held in a rabbi trust and include mutual funds and cash equivalents for payment of non-qualified benefits for certain retired, terminated or active employees. These investments are recorded to prepaid and other assets (current) or other assets (non-current) depending on their corresponding, anticipated distributions to recipients, which are reported in accrued expenses and other liabilities (current) or other long-term liabilities (non-current), respectively.

Foreign currency forward contracts are measured using the market approach on a recurring basis considering foreign currency spot rates and forward rates quoted by banks or foreign currency dealers (Level 2). See Note 8, "Derivatives and Hedging Activities". Foreign currency contracts are classified in the condensed consolidated balance sheet in prepaid expenses and other assets or accrued expenses and other liabilities, depending on the respective contracts' favorable or unfavorable positions.

The Company recorded a contingent consideration liability at the acquisition date of CDC representing the amounts payable to former CDC shareholders, as outlined under the terms of the Share Purchase and Sale Agreement, based upon the achievement of projected earnings, net of specific pro forma adjustments. The current and non-current portions of this obligation are reported separately on the condensed consolidated balance sheet. As the Company is still finalizing the valuation process, the fair value of the liability recorded at the acquisition date is subject to change with the corresponding change to goodwill. The fair value of this Level 3 liability is estimated using a probability-weighted discounted cash flow analysis. Subsequent changes in the fair value of these contingent consideration liabilities are recorded to the change in fair value of contingent consideration line item in the condensed consolidated income statement that is included in the calculation of operating income. Fluctuations due to foreign currency translation are captured in other comprehensive income through the changes in foreign currency translation adjustments line item as seen in Note 4, Comprehensive Income. The Company remeasured the fair value at December 31, 2011. Refer to Note 5 for further details.

The table below provides a summary of the changes in fair value of the Company's contingent consideration (Level 3) for the CDC earnout for the quarter and six months ended December 31, 2011:

 

     Contingent consideration for the
quarter ended December 31,		      Contingent consideration for the
six months ended December 31,		  
     2011     2010      2011     2010  
     (in thousands)  

Fair value at beginning of period

    $ 21,253      $ —         $ 23,794      $ —     

Issuance of contingent consideration

      —          —           —          —     

Payments

      —          —           —          —     

Change in fair value

      (722 )      —           172        —     

Fluctuation due to foreign currency translation

      (529 )      —           (3,964 )      —     
  

 

 

    

 

 

     

 

 

    

 

 

  

Fair value at end of period

    $ 20,002      $ —         $ 20,002      $ —     
  

 

 

    

 

 

     

 

 

    

 

 

  

In the current quarter, the Company recorded a $0.7 million gain on the change in fair value of the contingent consideration. The gain is the result of changes to projected revenues related to a vendor contract that resulted in a change in the mix and timing of product revenues and related operating expenses to support the business. In addition, volatility in the foreign exchange between the Brazilian real and the U.S. dollar has driven significant changes in the translation of the real denominated liability. For the quarter and six months ended December 31, 2011, foreign exchange fluctuation has attributed for $0.5 million and $4.0 million of the decrease in value of the contingent consideration.